KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

Market Cap	144.73B
Revenue (ttm)	85.34B
Net Income (ttm)	1.45B
Shares Out	10.91M
EPS (ttm)	132.69
PE Ratio	100.01
Forward PE	n/a
Dividend	50.00 (0.36%)
Ex-Dividend Date	Dec 29, 2025

Volume	10,353
Average Volume	10,506
Open	14,000
Previous Close	13,850
Day's Range	13,110 - 14,060
52-Week Range	12,900 - 19,900
Beta	1.24
RSI	42.71
Earnings Date	n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 032300

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.